COPD and Anticoagulation Therapy: Time for a New Approach?

References

• Chronic obstructive pulmonary disease (COPD). Available from: https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed August 6, 2021.
   Google Scholar
• Aleva FE, Voets LW, Simons SO, de Mast Q, van der Ven AJ, Heijdra YF. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis. Chest. 2017;151(3):544–554. doi:10.1016/J.CHEST.2016.07.034
   PubMed Web of Science ®Google Scholar
• Næss IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692–699. doi:10.1111/J.1538-7836.2007.02450.X
   PubMed Web of Science ®Google Scholar
• Heit J, Mohr D, Silverstein M, Petterson T, O’Fallon W, Melton L. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761–768. doi:10.1001/ARCHINTE.160.6.761
   PubMed Web of Science ®Google Scholar
• Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med. 1991;151(5):933–938. doi:10.1001/ARCHINTE.1991.00400050081016
   PubMedGoogle Scholar
• Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386–1389. doi:10.1016/S0140-6736(98)07534-5
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–3080. doi:10.1093/EURHEARTJ/EHU283
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/THORAXJNL-2011-201518
   PubMed Web of Science ®Google Scholar
• Wang C, Du M, Cao D, et al. A pathological study of in situ thrombosis of small pulmonary arteries and arterioles in autopsy cases of chronic cor pulmonale. Chin Med J (Engl). 1998;111(9):771–774.
   PubMed Web of Science ®Google Scholar
• Wojtan P, Mierzejewski M, Osińska I, Domagała-Kulawik J. Macrophage polarization in interstitial lung diseases. Cent J Immunol. 2016;2(2):159–164. doi:10.5114/CEJI.2016.60990
   Web of Science ®Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651. doi:10.1183/13993003.00651-2019
   PubMed Web of Science ®Google Scholar
• Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):71–77. doi:10.1513/PATS.200407-038MS
   PubMedGoogle Scholar
• Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest. 2010;138(1):47–51. doi:10.1378/CHEST.09-2764
   PubMed Web of Science ®Google Scholar
• Tillie-Leblond I, Marquette C, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med. 2006;144(6):390–396. doi:10.7326/0003-4819-144-6-200603210-00005
   PubMed Web of Science ®Google Scholar
• Shi X, Li H. Anticoagulation therapy in patients with chronic obstructive pulmonary disease in the acute exacerbation stage. Exp Ther Med. 2013;5(5):1367–1370. doi:10.3892/ETM.2013.1001
   PubMed Web of Science ®Google Scholar
• Liu Y, Meng X, Feng J, Zhou X, Zhu H. Hypereosinophilia with concurrent venous thromboembolism: clinical features, potential risk factors, and short-term outcomes in a Chinese cohort. Sci Rep. 2020;10(1):1–8. doi:10.1038/s41598-020-65128-4
   PubMed Web of Science ®Google Scholar
• Yildiz P, Oflaz H, Cine N, Erginel-ünaltuna N, Erzengin F, Yilmaz V. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD. Respir Med. 2003;97(12):1282–1288. doi:10.1016/J.RMED.2003.06.001
   PubMed Web of Science ®Google Scholar
• Su Y, Han W, Giraldo C, De LY, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 2012;19(5):819–825. doi:10.1165/AJRCMB.19.5.3091
   Web of Science ®Google Scholar
• Ogawa S, Shreeniwas R, Brett J, Clauss M, Furie M, Stern DM. The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function. Br J Haematol. 1990;75(4):517–524. doi:10.1111/J.1365-2141.1990.TB07792.X
   PubMed Web of Science ®Google Scholar
• Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol. 2012;29(1):88–97. DOI:10.1165/RCMB.2002-0228OC
   Web of Science ®Google Scholar
• Cella G, Sbarai A, Mazzaro G, et al. Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin Appl Thrombos/Hemost. 2016;7(3):205–208. DOI:10.1177/107602960100700304
   Web of Science ®Google Scholar
• Peinado VI, Barbera JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;159(5I):1605–1611. DOI:10.1164/AJRCCM.159.5.9807059
   Web of Science ®Google Scholar
• Libby P, Simon DI. Inflammation and Thrombosis. Circulation. 2001;103(13):1718–1720. doi:10.1161/01.CIR.103.13.1718
   PubMed Web of Science ®Google Scholar
• Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279(18):1477–1482. doi:10.1001/JAMA.279.18.1477
   PubMed Web of Science ®Google Scholar
• Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis = Arch Monaldi per Le Mal Del Torace. 1997;52(1):43–47.
   PubMedGoogle Scholar
• Mispelaere D, Glerant JC, Audebert M, Remond A, Sevestre-Pietri MA, Jounieaux V. [Pulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensations]. Rev Mal Respir. 2002;19(4):415–423. French.
   PubMed Web of Science ®Google Scholar
• Mejza F, Lamprecht B, Niżankowska-Mogilnicka E, Undas A. Arterial and venous thromboembolism in chronic obstructive pulmonary disease: from pathogenic mechanisms to prevention and treatment. Pneumonol Alergol Pol. 2015;83(6):485–494. doi:10.5603/PIAP.2015.0078
   PubMedGoogle Scholar
• Fraisse F, Holzapfel L, Couland J-M, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. J Pediatr. 2012;161(6):1109–1114. doi:10.1164/AJRCCM.161.4.9807025
   PubMedGoogle Scholar
• Ambrosetti M, Ageno W, Spanevello A, Salerno M, Pedretti RF. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res. 2003;112(4):203–207. doi:10.1016/J.THROMRES.2003.12.003
   PubMed Web of Science ®Google Scholar
• Licha CRM, McCurdy CM, Maldonado SM, Lee LS. Current management of acute pulmonary embolism. Ann Thorac Cardiovasc Surg. 2020;26(2):65. doi:10.5761/ATCS.RA.19-00158
   PubMed Web of Science ®Google Scholar
• Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):17559. doi:10.1161/JAHA.120.017559/FORMAT/EPUB
   PubMed Web of Science ®Google Scholar
• Schellings MWM, de Maat MPM, de Lathouder S, Weerkamp F. Prolonged prothrombin time after discontinuing vitamin K antagonist. Clin Chem. 2017;63(9):1442–1444. doi:10.1373/clinchem.2016.267245
   PubMed Web of Science ®Google Scholar
• Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K. Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res. 2011;128(4):e24–e28. doi:10.1016/J.THROMRES.2011.05.004
   PubMed Web of Science ®Google Scholar
• Beghé B, Verduri A, Roca M, Fabbri LM. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993–995. doi:10.1183/09031936.00180812
   PubMed Web of Science ®Google Scholar
• Dong F, Huang K, Ren X, Qumu S, Niu H, Al E. Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016–2017: a retrospective study. BMJ Open. 2021;11(2):e040560. doi:10.1136/BMJOPEN-2020-040560
   PubMed Web of Science ®Google Scholar
• Rizkallah J, Man S, Sin D. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009;135(3):786–793. doi:10.1378/CHEST.08-1516
   PubMed Web of Science ®Google Scholar
• Andersson C, Hansen PW, Steffensen IE, et al. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – a Danish nationwide registry-based study. Eur J Intern Med. 2019;63:56–61. doi:10.1016/J.EJIM.2019.02.014
   PubMed Web of Science ®Google Scholar
• Mao R, Tromeur C, Bazire A, et al. Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study. Eur Respir J. 2017;50(1). doi:10.1183/13993003.00094-2017
   PubMed Web of Science ®Google Scholar
• Piazza G, Goldhaber S, Kroll A, Goldberg R, Emery C, Spencer F. Venous thromboembolism in patients with chronic obstructive pulmonary disease. Am J Med. 2012;125(10):1010–1018. doi:10.1016/J.AMJMED.2012.03.007
   PubMed Web of Science ®Google Scholar
• Jiménez D, Agustí A, Tabernero E, et al. Effect of a pulmonary embolism diagnostic strategy on clinical outcomes in patients hospitalized for COPD exacerbation: a randomized clinical trial. JAMA. 2021;326(13):1277–1285. doi:10.1001/JAMA.2021.14846
   PubMed Web of Science ®Google Scholar
• Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 Report); 2018. Available from: www.goldcopd.org. Accessed August 6, 2021.
   Google Scholar
• Fritz MK, Kincaid SE, Sargent CG, Green AH, Davis GA. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center. J Thromb Thrombolysis. 2020;51(1):67–73. doi:10.1007/S11239-020-02144-1
   Web of Science ®Google Scholar